Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 18, 2014Journal of Clinical OncologyOpen Access

Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

JRJohn RaemaekersRadboud University NijmegenMAMarc AndréCentre Hospitalier Universitaire de BesançonMFMassimo FedericoUniversity of Modena and Reggio Emilia

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Raemaekers et al. (2014) studied this question.

synapsesocial.com/papers/6aa2f508a841a277b27f73e6https://doi.org/10.1200/jco.2013.51.9298
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Chemotherapy and radiotherapy in Hodgkin's lymphoma: joining in or splitting up?2006 · 2 citations
  2. 2Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials2006 · 230 citations
  3. 3Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8–9 April 20102010 · 133 citations
  4. 4Long-term Events in Adult Patients with Clinical Stage IA-IIA Nonbulky Hodgkin's Lymphoma Treated with Four Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Adjuvant Radiotherapy: A Single-Institution 15-Year Follow-up2006 · 96 citations